Pregled po CROSBI profilu: Marko Tarle (CROSBI Profil: 28281, MBZ: 71894)

1.

Knežević, Predrag; Tarle, Marko; Fratrić, Lucija Ida; Tarle, Antonia; Knežević-Krajina, Hana; Macan, Darko

Gingival Hypertrophy in a Child with Hyaline Fibromatosis Syndrome // Acta stomatologica Croatica, 54 (2020), 1; 69-74 doi:10.15644/asc54/1/8 (međunarodna recenzija, članak, stručni)

doi doi.org

2.

Petar Suton; Marin Prpic; Marko Tarle; Matija Mamic; Iva Nikles; Ivica Luksic;

Outcomes for patients with second primary malignancy after primary surgical treatment for early‐stage squamous cell carcinoma of the oral cavity // Head and neck-journal for the sciences and specialties of the head and neck, 40 (2018), 11; 2347-2352 doi:10.1002/hed.25330 (međunarodna recenzija, članak, znanstveni)

doi onlinelibrary.wiley.com www.ncbi.nlm.nih.gov

3.

Knežević, Predrag; Blivajs, Igor; Vuletić, Marko; Tarle, Marko

Macrostomia - Case Report // Abstract Book XXIV Congress of the European Association for Cranio–Maxillo–Facial Surgery/Munchen, Germany
München, Njemačka, 2018. str. 1274-1274 (poster, međunarodna recenzija, sažetak, stručni)

4.

Tarle, Marko

Polimorfizam CYP2C19 u bolesnika s kardioembolijskim događajem, 2015., diplomski rad, diplomski, Medicinski fakultet, Zagreb

5.

Trinajstić, Nenad; Tarle, Marko; Vančik, Hrvoj; Flegar, Vanja

Popis znanstvenih radova akademika Dionisa Emerika Sunka // Dionis Emerik Sunko 1922.- 2010. / Trinajstić, Nenad (ur.).
Zagreb: Hrvatska akademija znanosti i umjetnosti (HAZU), 2011. str. 43-55

6.

Tarle, Marko; Spajić, Borivoj; Kraljić, Ivo; Kusić, Zvonko

Continuos Finasteride Therapy for Benign Prostate Hypertrophy Upgrades Both Neuroendocrine Differentiation and Aggresive Prostate Cancer // Anticancer Research, 29 (2009), 5; 1797-1801 (međunarodna recenzija, članak, znanstveni)

www.researchgate.net

7.

Tarle, Marko; Spajić, Borislav; Kraljić, Ivan; Kusić, Zvonko

Continuous finasteride therapy for benign prostate hypertrophy upgrades both neuroendorcine differentiation and aggressive prostate cancer // Anticancer research, 29 (2009), 5; 1797-1801 (međunarodna recenzija, članak, znanstveni)

8.

Čustović, Zajim; Kraus, Ognjen; Tomašković, Igor; Tarle, Marko

Serum tPSA, cPSA, related density parameters and chromogranin A as predictors of positive margins after radical prostatectomy // Anticancer Research, 27 (2007), 4C; 2817-2821 (međunarodna recenzija, članak, znanstveni)

9.

Tarle, Marko; Kraljić, Ivo; Spajić, Borislav; Kusić, Zvonko

Prostate cancer progression and CgA elevation in pts with Gleason score (3+4, (4+3) and (3+3) // Book of Abstracts, The 15th International Prostate Cancer Update / David E Crawford (ur.).
Denver (CO): ICPME, 2005. str. 139-139 (predavanje, međunarodna recenzija, sažetak, znanstveni)

10.

Tarle, Marko; Kraljić, Ivo; Spajić, Borislav; Kusić, Zvonko

Prostate Cancer Progression and CgA Elevation in Patients With Gleason Scores 3+4, 4+3, 3+3 // Second Congress of the Croatian Society for Neurovascular Disorders with International Participation : Proceedings = Drugi kongres Hrvatskoga društva za neurovaskularne poremećaje Hrvatskoga liječničkog zbora s međunarodnim sudjelovanjem : Zbornik radova / Demarin, Vida ; Trkanjec, Zlatko ; Vuković, Vlasta (ur.).
Zagreb: Croatian Medical Association, 2005. str. 165-165 (poster, sažetak, znanstveni)

11.

Tarle, Marko; Novosel, Sunčica; Kovačić, Ksenija; Ahel, ZKusić, Zvonkoaky;

Chromogranin A as a marker of osteolysis in Stage D3 prostate cancer patients // Anticancer Research, 24 (2004), 3650-3651 (podatak o recenziji nije dostupan, kongresno priopcenje, ostalo)

12.

Tarle, Marko

Elevation in NE differentiation data and respective consequences in HRPC patients // Anticancer Research, 24 (2004) (podatak o recenziji nije dostupan, kongresno priopcenje, znanstveni)

13.

Tarle, Marko; Kovačić, Ksenija; Novosel, Sunčica; Ahel, Zaky

Multivariant tumor marker analysis in Stage D2 and D3 prostate cancer:The role of NE differentiation // Anticancer Research, 24 (2004), 3649-3650 (podatak o recenziji nije dostupan, kongresno priopcenje, znanstveni)

14.

Tarle, Marko; Petek, Iva; Novosel, Sunčica; Ahel, Zaky; Kusić, Zvonko

Latent hazard in PC and BPH patients referred to antiandrogens:PC aggressiveness and NE differentiation // Anticancer Research, 24 (2004), 3648-3649 (podatak o recenziji nije dostupan, kongresno priopcenje, znanstveni)

15.

Tarle, Marko; Petek, Iva; Novosel, Sunčica; Kraljić, Ivo; Spajić, Borislav; Kusić, Zvonko

Prolongation of Finasteride therapy may promote aggressive prostate cancer // Book of Abstracts, The 14th International Prostate Cancer Update / David E Crawford (ur.).
Denver (CO): ICPME, 2004. str. 134-134 (predavanje, međunarodna recenzija, sažetak, znanstveni)

16.

Tarle, Marko; Novosel, Sunčica; Kovačić, Ksenija; Ahel, Zaky; Kusić, Zvonko

Chromogranin A as a marker of osteolysis in stage D3 prostate cancer patients // Anticancer Research, 24 (2004), 5D. (podatak o recenziji nije dostupan, kongresno priopcenje, znanstveni)

17.

Tarle, Marko; Petek, Tarnik, Iva; Novosel, Sunčica; Ahel, Zaky; Kusić, Zvonko

Latent hazard in pc and bph patients referred to antiandrogens : pc aggressiveness and ne differentiation // Abstracts of the 7th international conference of anticancer research ; u: Anticancer research 24 (2004) (5d) 3393-3698 ; Abst.No. 501
Krf, Grčka, 2004. str. 3648- (poster, međunarodna recenzija, sažetak, znanstveni)

www.iiar-anticancer.org

18.

Tarle, Marko; Kraus, Ognjen; Trnski, Davor; Reljić, Ante; Ružić, Boris; Katušić, Josip; Spajić, Borislav; Kusić, Zvonko

Early diagnosis of prostate cancer in finasteride treated BPH patients // Anticancer Research, 23 (2003), 1B; 693-696 (međunarodna recenzija, članak, znanstveni)

19.

Novosel, Sunčica; Kovačić, Ksenija; Ahel, Zaky; Kraljić, Ivo; Kusuć, Zvonko; Tarle, Marko

Chromogranin A as a marker of osteolysis in Stage D3 prosatte cancer patients // Book of Abstracts, 13th International Prostate Cancer Update / E. David Crawford (ur.).
Denver (CO): icpme, 2003. str. 91-91 (predavanje, međunarodna recenzija, sažetak, znanstveni)

20.

Tarle, Marko; Kovačić, Ksenija; Kraljić, Ivo; Novosel, Sunčica; Kusić, Zvonko

Concept of HRPC conversion into a chronic disease // Book of Abstracts, 5th World Congress of Urological Research
London : Delhi: World Society of Urological Research, 2003. str. 128-128 (poster, međunarodna recenzija, sažetak, znanstveni)

21.

Tarle, Marko; Kovačić, Ksenija

Molecular markers in prostate cancer bone metastases // Journal of tumor marker oncology, 19 (2003), 4; 10-10 (međunarodna recenzija, članak, znanstveni)

22.

Tarle, Marko; Petek, Iva; Novosel, Sunčica; Kraljić, Ivo; Spajić, Boro; Kusić, Zvonko

Prolongation of Finasteride therapy may promote aggressive prostate cancer // Book of abstracts, 14th International Prostate Cancer Update / E. David Crawford (ur.).
Denver (CO): icpme, 2003. str. 114-114 (predavanje, međunarodna recenzija, sažetak, znanstveni)

23.

Kraljić, Ivo; Tarle, Marko

Natural history of NE differentiation and the respective consequences in Stage D3 prostate cancer patients // 8th Mediterranean Congress of Urology / Franco Di Silverio, Constantine Dimopoulos (ur.).
Heraklion: Mediterranean Urological Association, 2003. str. 97-97 (plenarno, međunarodna recenzija, sažetak, znanstveni)

24.

Novosel, Sunčica; Kovačić, Ksenija; Spajić, Boro; Trnski, Davor; Kusić, Zvonko; Tarle, Marko

Connection between bone scan data (blastic vs. lytic) and tumor marker data in Stage D2 and D3 prostate cancer // European School of Urology, Book od Abstracts
Bratislava, 2002. str. 79-79 (poster, međunarodna recenzija, neobjavljeni rad, znanstveni)

25.

Tarle, Marko; Kovačić, Ksenija

Tumor markers and bone scans in distinguishing hormone hypersensitive from hormone insensitive Stage D3 prostate cancer // 16th Congress of European Society for Urological Research, Book of Abstracts / Lucio Luciani, MD (ur.).
Rim: Omnia Meeting & Congressi-Roma, 2002. str. 69-70 (poster, međunarodna recenzija, sažetak, znanstveni)

26.

Tarle, Marko; Ahel, Zaky; Kovačić, Ksenija

Acquired neuroendocrine positivity during maximal androgen blockade in prostate cancer patients // Anticancer Research, 22 (2002), 2525-2529 (međunarodna recenzija, članak, znanstveni)

27.

Tarle, Marko; Trnski, Davor; Ružić, Boris; Spajić, Boro; Reljić, Ante; Anzulović, Zdravko; Katušić, Josip; Kraus, Ognjen; Ahel, Zaky; Kraljić, Ivo.

Neuroendocrine differentiation in subclinically detected prostate cancer and during a subsequent disease progression. // Anticancer Research / Delinassios, John (ur.).
Atena: International Institute for Anticancer Research, 2001. str. 1660-1661 (predavanje, međunarodna recenzija, sažetak, znanstveni)

28.

Tarle, Marko; Ahel, Zaky; Kovačić, Ksenija.

Neuroendocrine differentiation and androgen deficient environment in prostate cancer patients. // Anticancer Research / Delinassios, John (ur.).
Atena: International Institute for Anticancer Research, 2001. str. 1660-1660 (predavanje, međunarodna recenzija, sažetak, znanstveni)

29.

Tarle, Marko; Ahel, Zaky; Spajić, Borislav; Reljić, Ante; Kraljić, Ivo; Kovačić, Ksenija.

Maximal androgen blockade and neuroendocrine differentiation in prostate cancer patients. // Book of Abstracts, 4th World Congress of Urological Research. / Kiprianou, Natasha et all. (ur.).
Iowa City (IA): Society for Basic Urological Research, 2001. str. 52-52 (poster, međunarodna recenzija, sažetak, znanstveni)

30.

Tarle, Marko

Serum chromogranin A level vs. false negative F/TPSA data in prostate cancer diagnosis // European Urology, 38 (2000), 4; 505-505 (međunarodna recenzija, članak, znanstveni)

31.

Tarle, Marko

Serum Chromogranin A in metastatic prostate cancer patients // Anticancer Research, 16 (1999), 6; 5663-5666 (međunarodna recenzija, članak, znanstveni)

32.

Kovačić, Ksenija; Tarle, Marko; Kusić, Zvonko.

The role of bone scanning in the diagnosis and monitoring of patients with prostatic cancer // Acta clinica Croatica, 37 (1998), 3; 265-267 (podatak o recenziji nije dostupan, pregledni)

33.

Tarle, Marko; Reljić, Ante; Spajić, Boris; Ružić, Boris; Trnski, Davor; Kraus, Ognjen; Kraljić, Ivo.

Is Finasteride therapy of BPH a route to the early detection of prostzate cancer in situ? // Drugi hrvatski urološki kongres / Peterković, Vjerislav. (ur.).
Rijeka: Hrvatsko urološko društvo, 1998. str. 71-71 (predavanje, sažetak, znanstveni)

34.

Tarle, Marko

Supklinička dijagnostika i praćenje raka prostate. // Suvremeni pristupi u dijagnostici i liječenju raka prostate. / Šamija, Mirko. (ur.).
Zagreb: Klinika za tumore, Zagreb, 1998. str. 12-12 (pozvano predavanje, domaća recenzija, sažetak, pregledni)

35.

Tarle, Marko; Kraljić, Ivo; Kovačić, Ksenija; Trnski, Davor; Reljić, Ante

Serum TPS and a bone scan in estimating the rate of apoptosis in prostate cancer responders to therapy // From Tumor Biology to Clinical Oncology (Tumor Biology, Vol. 19, Suppl. 2, 1998)
Umeå, Švedska, 1998. str. 21-21 (poster, sažetak, znanstveni)

36.

Tarle, Marko; Kraus, Ognjen; Kraljić, Ivo; Trnski, Davor; Anzulović, Zdravko; Katušić, Josip; Reljić, Ante; Ružić, Boris

Subclinical distinction of symptomatic BPH from prostate cancer in Finasteride treated patients. // Journal of Tumor Marker Oncology. 13(2), 1998 Sum.
Lugano, Švicarska, 1998. str. 32-33 (poster, sažetak, znanstveni)

37.

Tarle, Marko; Kraljić, Ivo; Kovačić, Ksenija; Tarle, Robert; Kaštelan, Maja

T-PSA, NK activity and TPS value during prostate cancer progression and in responders to therapy. // Journal of tumor marker oncology, 13 (1998), 2; 33-33 (međunarodna recenzija, članak, znanstveni)

38.

Tarle, Marko; Kraljić, Ivo; Trnski, Davor; Reljić, Ante; Kovačić, Ksenija

Percent free PSA (%F-PSA) value in follow-up treatment of hormone sensitive prostate cancer. %F-PSA as a succeful prognosticator to hormone therapy. // Anticancer research, 18 (1998), 6c. (međunarodna recenzija, članak, znanstveni)

39.

Tarle, Marko; Kraljić, Ivo; Ružić, Boris; Anzulović, Zdravko; Trnski, Davor; Katušić, Josip; Reljić, Ante; Kovačić, Ksenija.

Conversion of hormone sensitive prostate cancer to hormone resistant disease: A subclinical detection. // Anticancer research, 18 (1998), 6c; 4958-4959 (međunarodna recenzija, članak, znanstveni)

40.

Tarle, Marko; Kraljić, Ivo; Kovačić, Ksenija; Trnski, Davor; Reljić, Ante

Serum TPS value and a bone scan in estimating the rate of apoptosis in prostate cancer responders to therapy and a probe used in staging protocols. // Anticancer research, 18 (1998), 6c; 4957-4957 (međunarodna recenzija, članak, znanstveni)

41.

Tarle, Marko; Reljić, Ante; Kraus, Ognjen; Kraljić, Ivo; Ruži, Boris; Trnski, Davor

A novel procedure for the detection of prostate cancer in situ by applying Finasteride therapy. // Anticancer research, 18 (1998), 6c; 4959-4959 (međunarodna recenzija, članak, znanstveni)

42.

Tarle, Marko

Analysis of TPS application in prostate cancer : a critical commentary // Journal of tumor marker oncology, 12 (1997), 2; 74-74 (međunarodna recenzija, članak, znanstveni)

43.

Kraljić, Ivo; Katušić, Josip; Trnski, Davor; Reljić, Ante; Anzulović, Zdravko; Ružić, Boris; Tarle, Marko

The use of free and total serum PSA values (F/T%PSA) in discriminating BPH from latent, manifest and "manifest-to-be" prostatic carcinoma // Journal of tumor marker oncology, 12 (1997), 4; 57-58 (podatak o recenziji nije dostupan, znanstveni)

44.

Tarle, Marko; Kraljić, Ivo

F/T%PSA values in patients with prostatic disorders and T-PSA ranging 3-15 ng/ml : introduction into the use in screening protocols // Tumor Biology, Suppl 2 (From Basic Cancer Research to Clinical Application)
Montreux, Švicarska, 1997. str. 29-29 (poster, sažetak, znanstveni)

45.

Kraljić, Ivo; Trnski, Davor; Reljić, Ante; Anzulović, Zdravko; Tarle, Marko

Introduction into the use of serum F/T%PSA value in distinguishing between BPH, latent and manifest prostatic adenocarcinoma // British journal of urology, 80 (1997), suppl. 2; 246-246 (međunarodna recenzija, članak, znanstveni)

46.

Ružić, Boris; Reljić, Ante; Trnski, Davor; Kraus, Ognjen; Anzulović, Zdravko; Katušić, Josip; Tarle, Marko

Multivariate analysis of serum tumor markers in prostate cancer patients treated with triptorelin and maximal androgen blockade // Acta clinica Croatica, 36 (1997), 1; 41-48 (podatak o recenziji nije dostupan, članak, stručni)

47.

Tarle, Marko; Kraljić, Ivo

Serum free/total percent PSA value as a clinical tool for discriminating latent from manifest prostatic carcinoma // Acta clinica Croatica, 36 (1997), 1; 15-20 (međunarodna recenzija, članak, znanstveni)

48.

Kaštelan, Marija; Kovačić, Ksenija; Tarle, Robert; Kraljić, Ivo; Tarle, Marko

Analysis of NK cell activity, lymphocyte reactivity to mitogens and serotest PSA and TPS values in patients with primary and disseminated prostate cancer // Anticancer research, 17 (1997), 3B; 1671-1676 (međunarodna recenzija, članak, znanstveni)

49.

Vrkić, Nada; Ružić, Dragica; Topić, Elizabeta; Petek, Marijan; Petek, Iva; Tarle, Marko; Lukinac, Ljerka

Evaluation of the fully automated ACS:180 plus chemiluminiscence system // The official publication of Medlab 97 : Abstracts / Vonderschmitt, Dieter J. (ur.).
Basel: Degra AG, Werbung/Marketing-Services, Rotkreuz, 1997. str. 233-233 (poster, međunarodna recenzija, sažetak, stručni)

50.

Tarle, Marko; Čulig, Zoran; Kovaček, Ivančica.

Unoccupied Prolactin Binding Components of the Bening and Maligant Human Prostate in a Subclinical and Clinical Procedure // Nuclear Medicine Biologorum, 00 (1989), 16; 461-467 (podatak o recenziji nije dostupan, pregledni rad, stručni)